The US Food and Drug Administration Sentinel System: a national resource for a learning health system

Author:

Brown Jeffrey S1ORCID,Mendelsohn Aaron B1,Nam Young Hee1,Maro Judith C1ORCID,Cocoros Noelle M1,Rodriguez-Watson Carla2,Lockhart Catherine M3,Platt Richard1,Ball Robert4ORCID,Dal Pan Gerald J4,Toh Sengwee1

Affiliation:

1. Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School , Boston, Massachusetts, USA

2. Reagan-Udall Foundation for the Food and Drug Administration , Washington, District of Columbia, USA

3. Biologics and Biosimilars Collective Intelligence Consortium , Alexandria, Virginia, USA

4. Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland, USA

Abstract

Abstract The US Food and Drug Administration (FDA) created the Sentinel System in response to a requirement in the FDA Amendments Act of 2007 that the agency establish a system for monitoring risks associated with drug and biologic products using data from disparate sources. The Sentinel System has completed hundreds of analyses, including many that have directly informed regulatory decisions. The Sentinel System also was designed to support a national infrastructure for a learning health system. Sentinel governance and guiding principles were designed to facilitate Sentinel’s role as a national resource. The Sentinel System infrastructure now supports multiple non-FDA projects for stakeholders ranging from regulated industry to other federal agencies, international regulators, and academics. The Sentinel System is a working example of a learning health system that is expanding with the potential to create a global learning health system that can support medical product safety assessments and other research.

Funder

U.S. Food and Drug Administration

Department of Health and Human Services

Publisher

Oxford University Press (OUP)

Subject

Health Informatics

Reference105 articles.

1. The U.S. Food and Drug Administration’s Mini-Sentinel program: status and direction;Platt;Pharmacoepidemiol Drug Saf,2012

2. Developing the Sentinel System–a national resource for evidence development;Behrman;N Engl J Med,2011

3. The FDA’s Sentinel Initiative—a comprehensive approach to medical product surveillance;Ball;Clin Pharmacol Ther,2016

4. The FDA Sentinel Initiative—an evolving national resource;Platt;N Engl J Med,2018

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3